# Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation

> **NCT02836067** · NA · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 53 (actual)

## Conditions studied

- HIV
- Smoking

## Interventions

- **BEHAVIORAL:** Counseling
- **OTHER:** Smoking Cessation drugs
- **PROCEDURE:** Bronchoscopy
- **PROCEDURE:** Blood Draw
- **BEHAVIORAL:** Questionnaires

## Key facts

- **NCT ID:** NCT02836067
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-15
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02836067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02836067, "Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02836067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*